When Miami lawyer Dan Dolan of Dolan Dobrinsky Rosenblum Bluestein recovered from a mild case of COVID-19, his first instinct was to donate convalescent plasma, which the Food and Drug Administration says can contain antibodies able to help seriously ill patients fight off the disease.

But after three weeks, he’s still trying to donate.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]